{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:06:01Z","timestamp":1784318761521,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006742.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000}}],"reference-count":160,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006742.pub3","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:44:52Z","timestamp":1758714292000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacotherapy for mild hypertension"],"prefix":"10.1002","volume":"2025","author":[{"given":"Dominic","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K","family":"Cundiff","sequence":"additional","affiliation":[{"name":"Formerly Internal Medicine at Los Angeles County + University of Southern California Medical Center; Independent researcher; San Anselmo California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Gueyffier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1; CNRS, LBBE (Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive), UMR 5558, Villeurbanne, F-69100; Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Grenet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1; CNRS, LBBE (Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive), UMR 5558, Villeurbanne, F-69100; Lyon France"},{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0211-8654","authenticated-orcid":false,"given":"Anshula","family":"Ambasta","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"21","key":"10.1002\/14651858.CD006742.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"9859","key":"10.1002\/14651858.CD006742.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"9349","key":"10.1002\/14651858.CD006742.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/s0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0004|cit4","volume-title":"Global Report on Hypertension: The Race Against a Silent Killer","author":"World Health Organization","year":"2023"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0005|cit5","first-page":"471","volume-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","volume":"1","author":"George","year":"2022"},{"issue":"8693","key":"10.1002\/14651858.CD006742.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-z","article-title":"Blood pressure, stroke, and coronary heart disease- Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD006742.pub3-BIB0007|cit7","first-page":"1","article-title":"New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit","volume":"10","author":"Gueyffier","year":"1996","journal-title":"Journal of Human Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD006742.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"issue":"19","key":"10.1002\/14651858.CD006742.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002146","article-title":"Pharmacotherapy for hypertension in women of different races","author":"Quan","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006742.pub3-BIB0011|cit11","first-page":"25","article-title":"Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?","volume":"161","author":"Wright","year":"1999","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub2","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000028.pub2","article-title":"Pharmacotherapy for hypertension in the elderly","author":"Musini","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD006742.pub3-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008276.pub2","article-title":"Pharmacotherapy for hypertension in adults aged 18 to 59 years","author":"Musini","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub3","article-title":"First-line drugs for hypertension","author":"Wright","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006742.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"38","key":"10.1002\/14651858.CD006742.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"European Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"issue":"691","key":"10.1002\/14651858.CD006742.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3399\/bjgp20X708053","article-title":"Diagnosis and management of hypertension in adults: NICE guideline update 2019","volume":"70","author":"Jones","year":"2020","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0021|cit21","unstructured":"World Health Organization Guideline for the Pharmacological Treatment of Hypertension in Adults Geneva World Health Organization https:\/\/iris.who.int\/bitstream\/handle\/10665\/344424\/9789240033986-eng.pdf"},{"issue":"692","key":"10.1002\/14651858.CD006742.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3399\/bjgp20X708461","article-title":"Corrections","volume":"70","year":"2020","journal-title":"British Journal of General Practice"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"e17508","DOI":"10.1371\/journal.pone.0017508","article-title":"The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies","volume":"6","author":"Marchant","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"e190406","DOI":"10.1001\/jamanetworkopen.2019.0406","article-title":"Prevalence of hypertension, treatment, and blood pressure targets in Canada associated with the 2017 American College of Cardiology and American Heart Association blood pressure guidelines","volume":"2","author":"Garies","year":"2019","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/HYPERTENSIONAHA.118.116","article-title":"Prevalence of hypertension and cardiovascular risk according to blood pressure thresholds used for diagnosis","volume":"72","author":"Lamprea-Montealegre","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/HYPERTENSIONAHA.121.18502","article-title":"Hypertension-mediated organ damage: Prevalence, correlates, and prognosis in the community","volume":"79","author":"Vasan","year":"2022","journal-title":"Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD006742.pub3-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006742.pub2","article-title":"Pharmacotherapy for mild hypertension","author":"Diao","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10285","key":"10.1002\/14651858.CD006742.pub3-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"The Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7326\/M14-0773","article-title":"Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis","volume":"162","author":"Sundstrom","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0030|cit30","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD006742.pub3-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013741","article-title":"First-line drug classes for hypertension in adults: a network meta-analysis","author":"Lunny","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0032|cit32","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0033|cit33","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.2"},{"issue":"d5928","key":"10.1002\/14651858.CD006742.pub3-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"11","key":"10.1002\/14651858.CD006742.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"22","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0036|cit36","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.1"},{"issue":"7454","key":"10.1002\/14651858.CD006742.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"8181","key":"10.1002\/14651858.CD006742.pub3-BIB0038|cit38","first-page":"1261","article-title":"The Australian Therapeutic Trial in Mild Hypertension. Report by the management committee","volume":"1","author":"The Australian Therapeutic Trial in Mild Hypertension","year":"1980","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006742.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00005344-198507002-00003","article-title":"Cardiovascular morbidity and mortality in mild hypertension: The Australian Trial","volume":"7","author":"Doyle","year":"1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.6.5.774","article-title":"The Australian Therapeutic Trial in Mild Hypertension","volume":"6","author":"Abernethy","year":"1984","journal-title":"Hypertension"},{"issue":"22","key":"10.1002\/14651858.CD006742.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1001\/jama.1986.03380220100031","article-title":"The need to treat mild hypertension. Misinterpretation of results from the Australian trial","volume":"256","author":"Abernethy","year":"1986","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD006742.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5694\/j.1326-5377.1981.tb101027.x","article-title":"Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia","volume":"2","author":"The Australian Therapeutic Trial in Mild Hypertension","year":"1981","journal-title":"Medical Journal of Australia"},{"issue":"8265","key":"10.1002\/14651858.CD006742.pub3-BIB0043|cit43","first-page":"185","article-title":"Untreated mild hypertension. A report by the management committee of the Australian Therapeutic Trial in Mild Hypertension","volume":"1","author":"The Australian Therapeutic Trial in Mild Hypertension","year":"1982","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006742.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000184567","article-title":"The Australian Therapeutic Trial in Mild Hypertension","volume":"47","author":"Doyle","year":"1987","journal-title":"Nephron"},{"issue":"8191","key":"10.1002\/14651858.CD006742.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(80)90471-7","article-title":"Australian therapeutic trial in mild hypertension","volume":"2","author":"Parry","year":"1980","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD006742.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5694\/j.1326-5377.1984.tb132588.x","article-title":"Australian therapeutic trial in mild hypertension","volume":"140","author":"Reader","year":"1984","journal-title":"Medical Journal of Australia"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD006742.pub3-BIB0047|cit47","first-page":"449s","article-title":"Initial results of the Australian Therapeutic Trial in mild hypertension: Report by the Management Committee","volume":"57","author":"The Australian Therapeutic Trial in Mild Hypertension","year":"1979","journal-title":"Clinical Science"},{"issue":"6488","key":"10.1002\/14651858.CD006742.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party","volume":"291","author":"Medical Research Council Working Party","year":"1985","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"6553","key":"10.1002\/14651858.CD006742.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.293.6553.988","article-title":"Course of blood pressure in mild hypertension after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension","volume":"293","author":"Medical Research Council Working Party","year":"1986","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"6636","key":"10.1002\/14651858.CD006742.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1136\/bmj.296.6636.1565","article-title":"Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party on Mild Hypertension","volume":"296","author":"Medical Research Council Working Party","year":"1988","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"6","key":"10.1002\/14651858.CD006742.pub3-BIB0051|cit51","first-page":"616","article-title":"Results of the MRC (UK) trial of drug therapy for mild hypertension","volume":"10","author":"Peart","year":"1987","journal-title":"Clinical & Investigative Medicine - Medecine Clinique et Experimentale"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0052|cit52","first-page":"563s","article-title":"Medical Research Council's Treatment Trial for mild hypertension: an interim report","volume":"3","author":"Miall","year":"1976","journal-title":"Clinical Science & Molecular Medicine - Supplement"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/hrt.59.3.364","article-title":"Coronary heart disease in medical research council trial of mild hypertension. Medical research council working party on mild hypertension","volume":"59","author":"Medical Research Council Working Party","year":"1988","journal-title":"British Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/j.1552-4604.1987.tb03012.x","article-title":"Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Research Council's trials of treatment of mild hypertension: Medical Research Council Working Party","volume":"27","author":"Medical Research Council Working Party","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6074","key":"10.1002\/14651858.CD006742.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.1.6074.1437","article-title":"Randomised controlled trial of treatment of mild hypertension: design and pilot trial. Report of the Medical Research Council Working Party on Mild to Moderate Hypertension","volume":"1","author":"Medical Research Council Working Party","year":"1977","journal-title":"British Medical Journal"},{"issue":"8246","key":"10.1002\/14651858.CD006742.pub3-BIB0056|cit56","first-page":"539","article-title":"Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension","volume":"2","author":"Medical Research Council Working Party","year":"1981","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD006742.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD006742.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1532-5415.1994.tb06979.x","article-title":"Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP","volume":"42","author":"Bearden","year":"1994","journal-title":"Journal of the American Geriatric Society"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0059|cit59","first-page":"II77","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 6: Baseline physical examination findings","volume":"17","author":"Black","year":"1991","journal-title":"Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD006742.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19970330)16:6<681::AID-SIM487>3.0.CO;2-H","article-title":"Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP)","volume":"16","author":"Brittain","year":"1997","journal-title":"Statistics in Medicine"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0061|cit61","first-page":"II35","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 4: Baseline medical history findings","volume":"17","author":"Curb","year":"1991","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0197-2456(93)90051-E","article-title":"Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP)","volume":"14","author":"Davis","year":"1993","journal-title":"Controlled Clinical Trials"},{"issue":"8","key":"10.1002\/14651858.CD006742.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)","volume":"18","author":"Franse","year":"2000","journal-title":"Journal of Hypertension"},{"issue":"10","key":"10.1002\/14651858.CD006742.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.CIR.94.10.2381","article-title":"Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP)","volume":"94","author":"Frost","year":"1996","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0065|cit65","first-page":"25","article-title":"Isolated systolic hypertension, morbidity, and mortality: The SHEP experience","volume":"2","author":"Hawkins","year":"1993","journal-title":"American Journal of Geriatric Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD006742.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0002-8703(94)90516-9","article-title":"Correlates of ventricular ectopic activity in isolated systolic hypertension. SHEP Cooperative Research Group","volume":"127","author":"Kostis","year":"1994","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD006742.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ajh\/5.5.325","article-title":"Some lessons from Systolic Hypertension in the Elderly Program (SHEP)","volume":"5","author":"Menard","year":"1992","journal-title":"American Journal of Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1532-5415.1997.tb03198.x","article-title":"Mortality over four years in SHEP participants with a low ankle-arm index","volume":"45","author":"Newman","year":"1997","journal-title":"Journal of American Geriatric Society"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.284.4.465","article-title":"Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)","volume":"284","author":"Davis","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"65p","DOI":"10.7326\/ACPJC-1991-115-3-065","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the SHEP","volume":"115","author":"SHEP cooperative research group","year":"1991","journal-title":"ACP Journal Club"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.1996.00440050111012","article-title":"Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group","volume":"156","author":"Wassertheil-Smoller","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archinte.160.4.494","article-title":"Relation of low body mass to death and stroke in the Systolic Hypertension in the Elderly Program. The SHEP Cooperative Research Group","volume":"160","author":"Wassertheil-Smoller","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD006742.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41371-019-0180-4","article-title":"Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program","volume":"33","author":"Kostis","year":"2019","journal-title":"Journal of Human Hypertension"},{"issue":"8 Pt 1","key":"10.1002\/14651858.CD006742.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/s0895-7061(01)02044-1","article-title":"Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group","volume":"14","author":"Kostis","year":"2001","journal-title":"American Journal of Hypertension"},{"issue":"5-6","key":"10.1002\/14651858.CD006742.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/10641968909035386","article-title":"The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension","volume":"11","author":"Probstfield","year":"1989","journal-title":"Clinical & Experimental Hypertension - Part A, Theory & Practice"},{"issue":"23","key":"10.1002\/14651858.CD006742.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0078|cit78","first-page":"II152","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 9: behavioral characteristics","volume":"17","author":"Weiler","year":"1991","journal-title":"Hypertension"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0079|cit79","first-page":"II162","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 10: analysis","volume":"17","author":"Wittes","year":"1991","journal-title":"Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0895-4356(88)90024-8","article-title":"Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group","volume":"41","author":"SHEP cooperative research group","year":"1988","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0081|cit81","first-page":"II2","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 1: rationale and design","volume":"17","author":"Borhani","year":"1991","journal-title":"Hypertension"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0082|cit82","first-page":"II102","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 7: baseline laboratory characteristics","volume":"17","author":"Hall","year":"1991","journal-title":"Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD006742.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","article-title":"Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group","volume":"158","author":"Savage","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0084|cit84","first-page":"II24","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 3: sociodemographic characteristics","volume":"17","author":"Vogt","year":"1991","journal-title":"Hypertension"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0085|cit85","first-page":"II123","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 8: electrocardiographic characteristics","volume":"17","author":"Kostis","year":"1991","journal-title":"Hypertension"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006742.pub3-BIB0086|cit86","first-page":"II16","article-title":"Systolic Hypertension in the Elderly Program (SHEP). Part 2: screening and recruitment","volume":"17","author":"Petrovitch","year":"1991","journal-title":"Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD006742.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1532-5415.1991.tb02869.x","article-title":"Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort","volume":"39","author":"Applegate","year":"1991","journal-title":"Journal of American Geriatric Society"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0002-9149(94)90904-0","article-title":"The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension. The SHEP Study Group","volume":"74","author":"Kostis","year":"1994","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.1978.tb25604.x","article-title":"Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension","volume":"304","author":"Veterans Administration - National Heart","year":"1978","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006742.pub3-BIB0090|cit90","first-page":"I180","article-title":"Treatment of mild hypertension. Preliminary results of a two year feasibility trial","volume":"40","year":"1977","journal-title":"Circulation Research"},{"issue":"18","key":"10.1002\/14651858.CD006742.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1161\/01.CIR.0000146378.65439.7A","article-title":"Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria","volume":"110","author":"Asselberg","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD006742.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0002-9149(00)01042-0","article-title":"Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT])","volume":"86","author":"Diercks","year":"2000","journal-title":"American Journal of Cardiology"},{"issue":"9B","key":"10.1002\/14651858.CD006742.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"9R","DOI":"10.1016\/S0002-9149(98)00750-4","article-title":"Antihypertensive therapy in type 2 diabetes: Implications of the appropriate blood pressure control in diabetes (ABCD) trial","volume":"82","author":"Estacio","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1007\/s001250050629","article-title":"Appropriate blood pressure control in NIDDM (ABCD) trial","volume":"39","author":"Schier","year":"1996","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006742.pub3-BIB0095|cit95","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"issue":"9590","key":"10.1002\/14651858.CD006742.pub3-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD006742.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006742.pub3-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s001250100612","article-title":"Study Rationale and Design in ADVANCE: Action in Diabetes and Vascular Disease - preterax and diamicron MR controlled evaluation","volume":"44","author":"ADVANCE Management Committee","year":"2001","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD006742.pub3-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/HYPERTENSIONAHA.114.04421","article-title":"Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: Results from action in diabetes and vascular disease: Preterax and diamicron MR controlled evaluation","volume":"65","author":"Leeuw","year":"2015","journal-title":"Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1681\/ASN.2006060560","article-title":"Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial","volume":"17","author":"Ruggenenti","year":"2006","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.111.174474","article-title":"Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial","volume":"58","author":"Ruggenenti","year":"2011","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0102|cit102","unstructured":"Delapril and manidipine for nephroprotection in diabetes (DEMAND) clinicaltrials.gov\/show\/NCT00157596"},{"issue":"7438","key":"10.1002\/14651858.CD006742.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.37970.629537.0D","article-title":"Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)","volume":"328","author":"Marre","year":"2004","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2215\/CJN.06870520","article-title":"Esaxerenone (CS-3150) in patients with type 2 diabetes and microalbuminuria (ESAX-DN): Phase 3 randomized controlled clinical trial","volume":"15","author":"Ito","year":"2020","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0105|cit105","unstructured":"A double blind study of CS-3150 to evaluate efficacy and safety compared to placebo in Japanese type 2 diabetic patients with microalbuminuria (ESAX-DN study) jrct.niph.go.jp\/latest-detail\/jRCT2080223639"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","article-title":"Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial","volume":"2","author":"Ando","year":"2014","journal-title":"Lancet Diabetes & Endocrinology"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0107|cit107","unstructured":"Eplerenone combination versus conventional agents to lower blood pressure on urinary antialbuminuric treatment effect trial - eplerenone combination versus conventional agents to lower blood pressure on urinary antialbuminuric treatment effect trial (EVALUATE) https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000001803"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0109|cit109","unstructured":"Felodipine event reduction study (FEVER) clinicaltrials.gov\/show\/NCT01136863"},{"issue":"16","key":"10.1002\/14651858.CD006742.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1056\/NEJM198210143071603","article-title":"The effect of treatment on mortality in \u201cmild\u201dhypertension Results of the hypertension detection and follow-up program","volume":"307","author":"Hypertension Detection and Follow-up Program Cooperative Group","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"2 Pt 2","key":"10.1002\/14651858.CD006742.pub3-BIB0111|cit111","first-page":"198","article-title":"Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-year findings of the hypertension detection and follow-up program","volume":"6","author":"Hypertension Detection and Follow-up Program Cooperative Group","year":"1984","journal-title":"Hypertension"},{"issue":"23","key":"10.1002\/14651858.CD006742.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.1979.03300230028022","article-title":"Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group","volume":"242","author":"Hypertension Detection and Follow-up Program Cooperative Group","year":"1979","journal-title":"JAMA"},{"issue":"23","key":"10.1002\/14651858.CD006742.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/jama.1979.03300230018021","article-title":"Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group","volume":"242","author":"Hypertension Detection and Follow-up Program Cooperative Group","year":"1979","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.1982.03320300037019","article-title":"Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group","volume":"247","author":"Hypertension Detection and Follow-up Program Cooperative Group","year":"1982","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple risk factor intervention trial research group","volume":"248","author":"Multiple Risk Factor Intervention Trial Research Group","year":"1982","journal-title":"JAMA"},{"issue":"13","key":"10.1002\/14651858.CD006742.pub3-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1001\/jama.1990.03440130083030","article-title":"Mortality rates after 10.5 years for participants in the multiple risk factor intervention trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group","volume":"263","author":"Multiple Risk Factor Intervention Trial Research Group","year":"1990","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD006742.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/01.CIR.102.15.1748","article-title":"Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin\/Enalapril Coronary Atherosclerosis Trial (SCAT)","volume":"102","author":"Teo","year":"2000","journal-title":"Circulation"},{"issue":"7160","key":"10.1002\/14651858.CD006742.pub3-BIB0118|cit118","first-page":"703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9131","key":"10.1002\/14651858.CD006742.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"6555","key":"10.1002\/14651858.CD006742.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.293.6555.1145","article-title":"Randomised trial of treatment of hypertension in elderly patients in primary care","volume":"293","author":"Coope","year":"1986","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"Article 154","key":"10.1002\/14651858.CD006742.pub3-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2020.00154","article-title":"Telmisartan and rosuvastatin synergistically ameliorate dementia and cognitive impairment in older hypertensive patients with apolipoprotein E genotype","volume":"12","author":"Hu","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"18","key":"10.1002\/14651858.CD006742.pub3-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/HJH.0000000000002346","article-title":"Atrial fibrillation and the risk of cardiovascular disease and mortality in the Hypertension in the Very Elderly Trial","volume":"38","author":"Antikainen","year":"2020","journal-title":"Journal of Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD006742.pub3-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1111\/j.1523-1755.2004.09213.x","article-title":"Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria","volume":"(92)","author":"Anavekar","year":"2004","journal-title":"Kidney International - Supplement"},{"issue":"7","key":"10.1002\/14651858.CD006742.pub3-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the irbesartan diabetic nephropathy trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"Berl","year":"2003","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ndt\/15.4.487","article-title":"The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group","volume":"15","author":"Rodby","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6824","key":"10.1002\/14651858.CD006742.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party","volume":"304","author":"MRC Working Party","year":"1992","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0129|cit129","unstructured":"Medical Research Council trial of treatment of mild hypertension isrctn.com\/ISRCTN72268178"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006742.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000184565","article-title":"Oslo study: treatment of mild hypertension. A five-year controlled drug study","volume":"47","author":"Helgeland","year":"1987","journal-title":"Nephron"},{"issue":"7-8","key":"10.1002\/14651858.CD006742.pub3-BIB0131|cit131","first-page":"79","article-title":"Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study","volume":"32","author":"Holme","year":"1982","journal-title":"Journal of the Oslo City Hospitals"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/oxfordjournals.aje.a114855","article-title":"Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study","volume":"127","author":"Holme","year":"1988","journal-title":"American Journal of Epidemiology"},{"issue":"2A","key":"10.1002\/14651858.CD006742.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(86)90153-1","article-title":"Coronary heart disease and treatment of hypertension. Some Oslo Study data","volume":"80","author":"Leren","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006742.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-198600311-00008","article-title":"Oslo hypertension study","volume":"31","author":"Leren","year":"1986","journal-title":"Drugs"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006742.pub3-BIB0135|cit135","first-page":"217","article-title":"Blood lipids and antihypertensive drugs. The Oslo study","volume":"14","author":"Leren","year":"1983","journal-title":"Journal de Pharmacologie"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD006742.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-8703(83)90175-8","article-title":"The Oslo study: CHD risk factors, socioeconomic influences, and intervention","volume":"106","author":"Leren P Hegeland A Hjermann","year":"1983","journal-title":"American Heart Journal"},{"issue":"Suppl. 626","key":"10.1002\/14651858.CD006742.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0954-6820.1979.tb00805.x","article-title":"Mild hypertension - early drug treatment or follow-up only? The Oslo study","volume":"205","author":"Helgeland","year":"1979","journal-title":"Acta Medica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD006742.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(78)90177-8","article-title":"Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study","volume":"64","author":"Helgeland A Hjermann I Holme","year":"1978","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0002-9343(84)90990-2","article-title":"Serum glucose levels during long-term observation of treated and untreated men with mild hypertension","volume":"76","author":"Helgeland","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9343(80)90438-6","article-title":"Treatment of mild hypertension: a five year controlled drug trial. The Oslo study","volume":"69","author":"Helgeland","year":"1980","journal-title":"American Journal of Medicine"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006742.pub3-BIB0141|cit141","first-page":"I98","article-title":"Treatment of mild hypertension: results of a ten-year intervention trial","volume":"40","author":"Smith","year":"1977","journal-title":"Circulation Research"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"9200","key":"10.1002\/14651858.CD006742.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006742.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(00)00736-1","article-title":"Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of atherosclerosis with ramipril","volume":"36","author":"MacMahon","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"9287","key":"10.1002\/14651858.CD006742.pub3-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD006742.pub3-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jgh3.12315","article-title":"Effect of telmisartan and vitamin E on liver histopathology with non-alcoholic steatohepatitis: A randomized, open-label, noninferiority trial","volume":"4","author":"Alam","year":"2020","journal-title":"JGH Open: an Open Access Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD006742.pub3-BIB0148|cit148","unstructured":"Telmisartan vs. Vitamin E in NASH Sri Lanka Clinical Trials Registry\/Show\/SLCTR\/2016\/013"},{"issue":"7","key":"10.1002\/14651858.CD006742.pub3-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006742.pub3-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/HJH.0000000000001652","article-title":"Visit-to-visit (long-term) and ambulatory (short-term) blood pressure variability to predict mortality in an elderly hypertensive population","volume":"36","author":"Chowdhury","year":"2018","journal-title":"Journal of Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD006742.pub3-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2215\/CJN.07370714","article-title":"Rate of change in renal function and mortality in elderly treated hypertensive patients","volume":"10","author":"Chowdhury","year":"2015","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"9731","key":"10.1002\/14651858.CD006742.pub3-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"f5680","key":"10.1002\/14651858.CD006742.pub3-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials","volume":"347","author":"Ninomiya","year":"2013","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9136","key":"10.1002\/14651858.CD006742.pub3-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/s0140-6736(98)04433-x","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril efficacy in nephropathy","volume":"352","author":"Ruggenenti","year":"1998","journal-title":"Lancet"},{"issue":"10017","key":"10.1002\/14651858.CD006742.pub3-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006742.pub3-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archinte.161.2.252","article-title":"Behavior of ambulatory blood pressure surrounding episodes of headache in mildly hypertensive patients","volume":"161","author":"Gus","year":"2001","journal-title":"Archives of Internal Medicine"},{"issue":"n189","key":"10.1002\/14651858.CD006742.pub3-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n189","article-title":"Association between antihypertensive treatment and adverse events: systematic review and meta-analysis","volume":"372","author":"Albasri","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"21","key":"10.1002\/14651858.CD006742.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006742.pub3-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","article-title":"Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults","volume":"174","author":"Tinetti","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006742.pub3-BIB0160|cit160","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006742","article-title":"Antihypertensive drugs for mild hypertension","author":"Wright","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006742.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:03:51Z","timestamp":1767200631000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006742.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":160,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006742.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}